XML 13 R1.htm IDEA: XBRL DOCUMENT v3.22.4
Document and Entity Information - USD ($)
12 Months Ended
Dec. 31, 2022
Feb. 24, 2023
Jun. 30, 2022
Document and Entity Information      
Document Type 10-K    
Document Annual Report true    
Document Transition Report false    
Entity Incorporation, State or Country Code NV    
Entity Address, Address Line One One Kendall Square    
Entity Address, Address Line Two Suite B14402    
Entity Address, City or Town Cambridge    
Entity Address, State or Province MA    
Document Period End Date Dec. 31, 2022    
Entity Registrant Name INVIVO THERAPEUTICS HOLDINGS CORP.    
Title of 12(b) Security Common Stock    
Trading Symbol NVIV    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
ICFR Auditor Attestation Flag false    
Entity Common Stock, Shares Outstanding   2,860,446  
Entity File Number 001-37350    
Entity Tax Identification Number 36-4528166    
Entity Address, Postal Zip Code 02139    
Local Phone Number 863-5500    
City Area Code 617    
Entity Public Float     $ 5,632,327
Auditor Name RSM US LLP    
Auditor Firm ID 49    
Auditor Location Massachusetts    
Entity Central Index Key 0001292519    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2022    
Document Fiscal Period Focus FY    
Amendment Flag false